Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
US Army
Harvard Business School

Generated: December 18, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

When do Paricalcitol patents expire, and what generic alternatives are available?

Paricalcitol is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Bionpharma Inc, Dr Reddys Labs Ltd, Eci Pharms Llc, Marksans Pharma, Rising Pharms Inc, Teva Pharms Usa, Accord Hlthcare, Akorn, Amneal Pharms Co, Hikma Pharms, Hospira Inc, Mylan Labs Ltd, and Sandoz Inc. and is included in sixteen NDAs.

The generic ingredient in PARICALCITOL is paricalcitol. There are ten drug master file entries for this compound. Nineteen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the paricalcitol profile page.
Drug patent expirations by year for PARICALCITOL

Pharmacology for PARICALCITOL

Drug ClassVitamin D3 Analog

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs LtdPARICALCITOLparicalcitolSOLUTION;INTRAVENOUS203897-001Nov 2, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdPARICALCITOLparicalcitolSOLUTION;INTRAVENOUS204910-001Aug 17, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz IncPARICALCITOLparicalcitolSOLUTION;INTRAVENOUS091108-002Jul 27, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
AkornPARICALCITOLparicalcitolSOLUTION;INTRAVENOUS207692-001Oct 16, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdPARICALCITOLparicalcitolSOLUTION;INTRAVENOUS204910-002Aug 17, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms CoPARICALCITOLparicalcitolSOLUTION;INTRAVENOUS206699-001Mar 9, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Amneal PharmsPARICALCITOLparicalcitolCAPSULE;ORAL204327-001Jan 13, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Marksans PharmaPARICALCITOLparicalcitolCAPSULE;ORAL204948-003Oct 7, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms UsaPARICALCITOLparicalcitolCAPSULE;ORAL090829-003Sep 27, 2013ABRXNoYes► Subscribe► Subscribe► Subscribe
Hospira IncPARICALCITOLparicalcitolSOLUTION;INTRAVENOUS201657-002Oct 21, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim
US Army
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: